Bangkok Genomics Innovation PCL (BKK:BKGI)

BKK:BKGI Balance Sheet

Financials in millions THB. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	132.91	221.74	389.93	165.9	148.34
Short-Term Investments	-	-	-	-	0.02
Cash & Short-Term Investments	132.91	221.74	389.93	165.9	148.36
Cash Growth	-63.09%	-43.13%	135.03%	11.83%	-
Accounts Receivable	116.94	148.06	71.17	26.96	31.36
Other Receivables	21.78	18.33	9.05	2.21	7.5
Receivables	138.72	166.39	80.22	29.17	38.86
Inventory	78.93	36.09	22.09	10.05	20.27
Prepaid Expenses	143.06	145.18	11.62	6.95	-
Other Current Assets	109.87	10.95	11.06	-	2.9
Total Current Assets	603.5	580.36	514.92	212.08	210.39
Property, Plant & Equipment	83.14	76.74	78.95	70.4	82.16
Long-Term Investments	0.54	0.59	0.92	-	-
Other Intangible Assets	23.59	22.94	0.48	1.08	1.38
Long-Term Deferred Tax Assets	1.63	1.27	0.92	0.76	0.39
Other Long-Term Assets	30.35	19.97	11.41	8.71	6.26
Total Assets	742.75	701.86	607.6	293.02	300.58

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Accounts Payable	93.38	82.39	23.76	11.69	2.49
Accrued Expenses	10.19	14.61	5.99	6.88	8.5
Current Portion of Leases	5.02	4.87	4.21	4.29	4.16
Current Income Taxes Payable	4.82	1.73	0.27	0.08	-
Current Unearned Revenue	11.85	13.15	5.28	9.32	1.94
Other Current Liabilities	10.22	10.08	6.15	3.3	6.85
Total Current Liabilities	135.47	126.82	45.68	35.56	23.94
Long-Term Leases	14.05	16.6	19.79	19.43	27.47
Pension & Post-Retirement Benefits	6.03	5.28	2.97	2.2	1.49
Total Liabilities	155.56	148.7	68.44	57.2	52.9

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Common Stock	300	300	300	220	220
Additional Paid-In Capital	171.21	171.21	171.21	-	-
Retained Earnings	113.83	81.69	66.3	16.12	27.98
Comprehensive Income & Other	-1.49	-1.68	-0.31	-0.31	-0.31
Total Common Equity	583.55	551.23	537.2	235.82	247.68
Minority Interest	3.64	1.93	1.95	-	-
Shareholders' Equity	587.19	553.15	539.15	235.82	247.68
Total Liabilities & Equity	742.75	701.86	607.6	293.02	300.58

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Total Debt	19.08	21.47	24	23.72	31.63
Net Cash (Debt)	113.84	200.27	365.93	142.18	116.73
Net Cash Growth	-66.34%	-45.27%	157.36%	21.80%	-
Net Cash Per Share	0.19	0.33	0.65	0.32	0.55
Filing Date Shares Outstanding	600	600	600	440	213.88
Total Common Shares Outstanding	600	600	600	440	213.88
Working Capital	468.02	453.53	469.25	176.51	186.45
Book Value Per Share	0.97	0.92	0.90	0.54	1.16
Tangible Book Value	559.97	528.29	536.73	234.74	246.3
Tangible Book Value Per Share	0.93	0.88	0.89	0.53	1.15
Machinery	-	117.67	102.03	80.83	73.63

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 11, 2026

Data Sources Report a data error